Real-life Outcomes of Tenofovir Disoproxil Fumarate Monotherapy in Nucleos(t)ide Analogue-naive and Nucleos(t)ide Analogue-experienced Chronic Hepatitis B Patients: A Single-center Experience


Creative Commons License

KORKMAZ P. , Caglan F. C. , Aykin N., NAZ H., TOKA O.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, vol.22, no.3, pp.92-96, 2016 (Journal Indexed in ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 22 Issue: 3
  • Publication Date: 2016
  • Doi Number: 10.4274/vhd.94830
  • Title of Journal : VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
  • Page Numbers: pp.92-96

Abstract

Objective: The aim of the study was to evaluate the long-term results of treatment efficacy and safety in nucleos(t)ide analogue-naive (NA-naive) and NA-experienced chronic hepatitis B (CHB) patients receiving tenofovir disoproxil fumarate (TDF) therapy.